(Q46896371)

26 December 2017

title

Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice (English)

1 reference

26 December 2017

0 references

0 references

Graciela N Balerio

1

1 reference

26 December 2017

Ester Aso

series ordinal

2

1 reference

26 December 2017

Rafael Maldonado

series ordinal

3

1 reference

26 December 2017

publication date

14 January 2006

1 reference

26 December 2017

published in

Psychopharmacology

1 reference

26 December 2017

volume

184

1 reference

26 December 2017

issue

3-4

1 reference

26 December 2017

page(s)

504-513

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0251-9

exact match

0 references

cites work

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0251-9

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0251-9

Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization.

21 January 2018

1 reference

12 December 2020

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

1 reference

12 December 2020

Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats

1 reference

12 December 2020

Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.

1 reference

12 December 2020

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

1 reference

12 December 2020

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

1 reference

12 December 2020

Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study

1 reference

12 December 2020

Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain

1 reference

12 December 2020

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

1 reference

12 December 2020

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

1 reference

12 December 2020

Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie.

1 reference

12 December 2020

Social isolation modifies nicotine's effects in animal tests of anxiety

1 reference

12 December 2020

Cannabinoid pharmacology

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid.

1 reference

12 December 2020

Nicotine-induced conditioned place preference and conditioned place aversion in mice.

1 reference

12 December 2020

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

1 reference

12 December 2020

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.

1 reference

12 December 2020

The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat

1 reference

12 December 2020

Nicotinic--serotonergic interactions in brain and behaviour

1 reference

12 December 2020

Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice

1 reference

12 December 2020

Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors.

1 reference

12 December 2020

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity

1 reference

12 December 2020

Involvement of CB1 cannabinoid receptors in emotional behaviour.

1 reference

12 December 2020

Norepinephrine depletion impairs neuroendocrine responses to fear but not novel environmental stimuli in the rat.

1 reference

12 December 2020

Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain

1 reference

12 December 2020

The actions of nicotine and cocaine in a mouse model of anxiety

1 reference

12 December 2020

Anxiolytic-like action of intra-hippocampally administered NMDA antagonists in rats.

1 reference

12 December 2020

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

1 reference

12 December 2020

Nicotine as a psychoactive drug: anxiety and pain reduction.

1 reference

12 December 2020

Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo

1 reference

12 December 2020

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

12 December 2020

Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice

1 reference

12 December 2020

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

1 reference

12 December 2020

The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.

1 reference

12 December 2020

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

1 reference

12 December 2020

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

12 December 2020

Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment

1 reference

12 December 2020

Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.

1 reference

12 December 2020

Overview of nicotinic receptors and their roles in the central nervous system

1 reference

12 December 2020

Nicotinic receptors in the brain. Links between molecular biology and behavior.

1 reference

12 December 2020

Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.

1 reference

12 December 2020

The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats

1 reference

12 December 2020

Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.

1 reference

12 December 2020

10.1007/S00213-005-0251-9

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16416159

1 reference

26 December 2017